Pasithea Therapeutics Corp. (KTTA) NASDAQ

3.01

-0.14(-4.43%)

Updated at January 02 10:20AM

Currency In USD

Pasithea Therapeutics Corp.

Address

1111 Lincoln Road

Miami Beach, FL 33139

United States of America

Phone

702 514 4174

Sector

Healthcare

Industry

Biotechnology

Employees

8

First IPO Date

September 15, 2021

Key Executives

NameTitlePayYear Born
Dr. Tiago Reis Marques M.D., Ph.D.Chief Executive Officer & Director480,0001977
Dr. Lawrence Steinman BA, M.D., Ph.D.Co-Founder, MD & Executive Chairman250,0001948
Mr. Daniel H. SchneidermanChief Financial Officer345,9391978
Dr. Graeme Currie Ph.D.Chief Development Officer346,6171967
Dr. Yassine Bendiabdallah Ph.D.Chief Operating Officer & Head of UK Clinics01984

Description

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.